Home > Insider Trading > Filing (0001209191-15-070808)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367920	Concert Pharmaceuticals Inc.	CNCE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594782	Pauline Mcgowan	C/O Concert Pharmaceuticals, Inc. 99 Hayden Avenue, Suite 500 Lexington MA 02421	Vp, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-09-14	497	$3.50	497	No	4	M	Direct
Common Stock	Disposition	2015-09-14	497	$18.97	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-09-14	497	$0.00	497	$3.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
498		2021-12-12	No	4	M	Direct

Footnotes

This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $18.79 to $19.25 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price
This option vested as to 6.25% of the original 7,964 shares on March 12, 2012 and vests as to an additional 6.25% of the original shares at the end of each successive three-month period through and including December 12, 2015.